Literature DB >> 15527638

Elevated serum parathormone after Roux-en-Y gastric bypass.

Maria de Fátima Haueisen Sander Diniz1, Marco Túlio Costa Diniz, Soraya Rodrigues Almeida Sanches, Patrícia Paz Cabral de Almeida Salgado, Maristane Mendes Andrade Valadão, Flávia Caldeira Araújo, Daniele Siríaco Martins, Alexandre Lages Savassi Rocha.   

Abstract

BACKGROUND: Abnormalities in calcium and vitamin D metabolism are observed early after gastric bypass, whereas clinical or biochemical evidence of metabolic bone disease might not be detected until many years after the procedure. The aim of the present study was to evaluate the impact of bariatric surgery on bone metabolism determined on the basis of postoperative laboratory changes in calcium, phosphorus, magnesium, alkaline phosphatase and parathormone (PTH) levels.
METHODS: 110 patients submitted to Roux-en-Y gastric bypass (RYGBP) were followed after surgery, and the following parameters were determined: intact PTH molecule (PTHi; chemiluminescence), alkaline phosphatase (colorimetric method), ionic calcium (selective electrode), phosphorus and magnesium (colorimetric method).
RESULTS: Elevated serum PTHi levels were observed in 29% of the patients and hypocalcemia in 0.9% from the 3rd postoperative month and afterwards (3 to 80 months after surgery).
CONCLUSION: There is a need for careful evaluation of bone metabolism and for routine calcium replacement after RYGBP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527638     DOI: 10.1381/0960892042386959

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  20 in total

1.  Increased plasma magnesium concentrations 3 years after biliopancreatic diversion with duodenal switch.

Authors:  Jakob Hedberg; Arvo Haenni
Journal:  Obes Surg       Date:  2012-11       Impact factor: 4.129

2.  Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up.

Authors:  Nuria Vilarrasa; Patricia San José; Isabel García; Carmen Gómez-Vaquero; Pilar Medina Miras; Amador G Ruiz de Gordejuela; Carles Masdevall; Jordi Pujol; Joan Soler; José Manuel Gómez
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

Review 3.  Nutritional deficiencies after bariatric surgery.

Authors:  D J Davies; J M Baxter; J N Baxter
Journal:  Obes Surg       Date:  2007-09       Impact factor: 4.129

4.  Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery on obese women.

Authors:  Maria de Fátima Haueisen Sander Diniz; Flávia Caldeira Araújo; Marco Túlio Costa Diniz
Journal:  Surg Endosc       Date:  2008-06-21       Impact factor: 4.584

Review 5.  Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.

Authors:  M P Hage; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2013-09-06       Impact factor: 4.507

6.  Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.

Authors:  Adrian Mahlmann; Siegmund Gehrisch; Jan Beyer-Westendorf
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

7.  Hypocalcemia After Bariatric Surgery: Prevalence and Associated Risk Factors.

Authors:  Meera Shah; Anu Sharma; Robert A Wermers; Kurt A Kennel; Todd A Kellogg; Manpreet S Mundi
Journal:  Obes Surg       Date:  2017-11       Impact factor: 4.129

8.  Need for multivitamin use in the postoperative period of gastric bypass.

Authors:  Fernanda G Colossi; Daniela S Casagrande; Raquel Chatkin; Myriam Moretto; Anália S Barhouch; Giuseppe Repetto; Alexandre V Padoin; Cláudio C Mottin
Journal:  Obes Surg       Date:  2007-12-28       Impact factor: 4.129

9.  Calcium intake and metabolic bone disease after eight years of Roux-en-Y gastric bypass.

Authors:  Camila Duran de Campos; Lorença Dalcanale; Denis Pajecki; Arthur B Garrido; Alfredo Halpern
Journal:  Obes Surg       Date:  2008-01-31       Impact factor: 4.129

10.  Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding.

Authors:  Mary DiGiorgi; Amna Daud; William B Inabnet; Beth Schrope; Meredith Urban-Skuro; Nancy Restuccia; Marc Bessler
Journal:  Obes Surg       Date:  2008-03-12       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.